119-hres277

HRES
✓ Complete Data

Supporting the designation of May 2025 as "National Myositis Awareness Month".

Login to track bills
Introduced:
Mar 31, 2025
Policy Area:
Health

Bill Statistics

3
Actions
2
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Mar 31, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Mar 31, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: H11100
Mar 31, 2025
Submitted in House
Type: IntroReferral | Source: Library of Congress | Code: 1025
Mar 31, 2025

Subjects (1)

Health (Policy Area)

Cosponsors (2)

(R-TX)
May 15, 2025
(D-NY)
May 7, 2025

Text Versions (1)

Introduced in House

Mar 31, 2025

Full Bill Text

Length: 2,603 characters Version: Introduced in House Version Date: Mar 31, 2025 Last Updated: Nov 15, 2025 6:22 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 277 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. RES. 277

Supporting the designation of May 2025 as ``National Myositis Awareness
Month''.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

March 31, 2025

Mr. McCormick submitted the following resolution; which was referred to
the Committee on Energy and Commerce

_______________________________________________________________________

RESOLUTION

Supporting the designation of May 2025 as ``National Myositis Awareness
Month''.

Whereas residents of the United States of America are among those affected by
myositis and other rare diseases, with nearly 1 in 10 Americans having
rare diseases;
Whereas idiopathic inflammatory myopathies (collectively referred to as
myositis) are rare, chronic, autoimmune muscle-wasting diseases that
often feature debilitating muscle inflammation and other symptoms, such
as pain, fatigue, and trouble swallowing, and can result in myositis-
associated interstitial lung disease;
Whereas more research is needed to identify the causes of and modes of
treatments for the myositis group of diseases, which includes anti-MDA5
autoantibody-positive myositis, antisynthetase syndrome,
dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing
myopathy, inclusion body myositis, and polymyositis;
Whereas myositis is difficult to diagnose which leads myositis patients to
frequently experience delayed treatment and difficulty finding a health
care provider with expertise in their condition;
Whereas all who suffer with myositis experience reduced quality of life,
particularly since no cure has been found and life expectancy is
shortened, especially for those with inclusion body myositis, and women
and people of color with all forms of myositis experience particularly
pronounced health disparities; and
Whereas public awareness and education campaigns on myositis detection and
treatment are held during the month of May: Now, therefore, be it
Resolved, That the House of Representatives--

(1) supports the designation of ``National Myositis
Awareness Month'';

(2) recognizes the importance of raising awareness about
myositis and its impact on United States veterans and citizens;
and

(3) encourages all people in the United States to become
more informed about myositis and to support the individuals and
families who are affected by these conditions.
<all>